17 beta-Hydroxysteroid dehydrogenase activity in human breast epithelial cell and fibroblast cultures. 1984

J F Prud'homme, and C Malet, and A Gompel, and J P Lalardrie, and C Ochoa, and A Boue, and P Mauvais-Jarvis, and F Kuttenn

Primary cultures of human breast cells prepared from surgical specimens of reduction mammoplasty were used to study the activity of the enzyme 17 beta-hydroxysteroid dehydrogenase (E2DH) which converts estradiol (E2) into its less active metabolite estrone. This study was performed in both epithelial and stromal cells separated, after collagenase digestion of the tissue, on a Percoll gradient, and then cultured as monolayers in Ham's F 10 medium supplemented differently for epithelial cells and fibroblasts. E2DH activity was strikingly higher in epithelial cells than in fibroblasts, since after [3H]E2 incubation (2 nM), 600 fmol/micrograms DNA were metabolized to estrone in epithelial cells after 1 h, whereas an equivalent amount was hardly obtained in fibroblast cultures after 24 h. The affinity and capacity of E2DH were greater in epithelial cells with apparent Michaelis-Menten constant (Km) = 0.6 +/- 0.1 microM and maximum velocity (Vmax) = 250 to 360 pmol/micrograms DNA/h, whereas they were 10 +/- 1 microM and 50 to 70 pmol/micrograms DNA/h, respectively, in fibroblast cultures. Moreover, the E2DH activity was 2 to 5 times higher in epithelial cells cultured in the presence of the progestin medroxyprogesterone acetate, whereas it remained unchanged in fibroblasts cultured under the same conditions. This increase in E2DH activity was dose dependent from 10(-10) to 10(-7) M medroxyprogesterone acetate and inhibited by both actinomycin D and cycloheximide. This system of differential breast cell culture appears to be a fruitful tool for the study of the hormone dependence of normal breast growth and differentiation. Due to the presence of E2DH, epithelial cells are more apt to undergo and to moderate E2 action. Moreover, epithelial cells are a possible site of progesterone modulation of E2DH activity. Therefore, E2DH could be a good marker both for epithelial cells and their hormone dependence.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008525 Medroxyprogesterone A synthetic progestational hormone used in veterinary practice as an estrus regulator. (6 alpha)-17-Hydroxy-6-methylpregn-4-ene-3,20-dione,Methylhydroxyprogesterone,Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6alpha)-,17 alpha-Hydroxy-6 alpha-Methylprogesterone,Adgyn Medro,17 alpha Hydroxy 6 alpha Methylprogesterone
D001940 Breast In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES. Breasts
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003271 Contraceptive Agents, Female Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading. Contraceptives, Female,Agents, Female Contraceptive,Female Contraceptive Agents,Female Contraceptives
D003609 Dactinomycin A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) Actinomycin,Actinomycin D,Meractinomycin,Cosmegen,Cosmegen Lyovac,Lyovac-Cosmegen,Lyovac Cosmegen,Lyovac, Cosmegen,LyovacCosmegen
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004848 Epithelium The layers of EPITHELIAL CELLS which cover the inner and outer surfaces of the cutaneous, mucus, and serous tissues and glands of the body. Mesothelium,Epithelial Tissue,Mesothelial Tissue,Epithelial Tissues,Mesothelial Tissues,Tissue, Epithelial,Tissue, Mesothelial,Tissues, Epithelial,Tissues, Mesothelial
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D005260 Female Females

Related Publications

J F Prud'homme, and C Malet, and A Gompel, and J P Lalardrie, and C Ochoa, and A Boue, and P Mauvais-Jarvis, and F Kuttenn
September 1982, The Journal of clinical endocrinology and metabolism,
J F Prud'homme, and C Malet, and A Gompel, and J P Lalardrie, and C Ochoa, and A Boue, and P Mauvais-Jarvis, and F Kuttenn
September 1967, Acta endocrinologica,
J F Prud'homme, and C Malet, and A Gompel, and J P Lalardrie, and C Ochoa, and A Boue, and P Mauvais-Jarvis, and F Kuttenn
September 1964, Biochimica et biophysica acta,
J F Prud'homme, and C Malet, and A Gompel, and J P Lalardrie, and C Ochoa, and A Boue, and P Mauvais-Jarvis, and F Kuttenn
July 1996, Neuroendocrinology,
J F Prud'homme, and C Malet, and A Gompel, and J P Lalardrie, and C Ochoa, and A Boue, and P Mauvais-Jarvis, and F Kuttenn
November 1986, The Journal of clinical endocrinology and metabolism,
J F Prud'homme, and C Malet, and A Gompel, and J P Lalardrie, and C Ochoa, and A Boue, and P Mauvais-Jarvis, and F Kuttenn
April 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
J F Prud'homme, and C Malet, and A Gompel, and J P Lalardrie, and C Ochoa, and A Boue, and P Mauvais-Jarvis, and F Kuttenn
November 1996, The Journal of clinical endocrinology and metabolism,
J F Prud'homme, and C Malet, and A Gompel, and J P Lalardrie, and C Ochoa, and A Boue, and P Mauvais-Jarvis, and F Kuttenn
April 1988, Biochemical and biophysical research communications,
J F Prud'homme, and C Malet, and A Gompel, and J P Lalardrie, and C Ochoa, and A Boue, and P Mauvais-Jarvis, and F Kuttenn
June 1990, Nihon Sanka Fujinka Gakkai zasshi,
J F Prud'homme, and C Malet, and A Gompel, and J P Lalardrie, and C Ochoa, and A Boue, and P Mauvais-Jarvis, and F Kuttenn
November 1993, The Journal of steroid biochemistry and molecular biology,
Copied contents to your clipboard!